These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30761393)

  • 1. Active uptake of hydrophilic copper complex Cu(ii)-TETA in primary cultures of neonatal rat cardiomyocytes.
    Fu C; Lizhao J; Luo Z; Wang T; Grapperhaus CA; Ding X; Kang YJ
    Metallomics; 2019 Mar; 11(3):565-575. PubMed ID: 30761393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
    Nurchi VM; Crisponi G; Crespo-Alonso M; Lachowicz JI; Szewczuk Z; Cooper GJ
    Dalton Trans; 2013 May; 42(17):6161-70. PubMed ID: 23202417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.
    Bass LA; Wang M; Welch MJ; Anderson CJ
    Bioconjug Chem; 2000; 11(4):527-32. PubMed ID: 10898574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation.
    Zhang S; Liu H; Amarsingh GV; Cheung CC; Hogl S; Narayanan U; Zhang L; McHarg S; Xu J; Gong D; Kennedy J; Barry B; Choong YS; Phillips AR; Cooper GJ
    Cardiovasc Diabetol; 2014 Jun; 13():100. PubMed ID: 24927960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
    Cooper GJ
    Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.
    Lu J; Gong D; Choong SY; Xu H; Chan YK; Chen X; Fitzpatrick S; Glyn-Jones S; Zhang S; Nakamura T; Ruggiero K; Obolonkin V; Poppitt SD; Phillips AR; Cooper GJ
    Diabetologia; 2010 Jun; 53(6):1217-26. PubMed ID: 20221822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy.
    Zuo X; Xie H; Dong D; Jiang N; Zhu H; Kang YJ
    Cardiovasc Toxicol; 2010 Sep; 10(3):208-15. PubMed ID: 20582486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes.
    Tremmel R; Uhl P; Helm F; Wupperfeld D; Sauter M; Mier W; Stremmel W; Hofhaus G; Fricker G
    Int J Pharm; 2016 Oct; 512(1):87-95. PubMed ID: 27553779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper accumulation by cultured astrocytes.
    Scheiber IF; Mercer JF; Dringen R
    Neurochem Int; 2010 Feb; 56(3):451-60. PubMed ID: 20004225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper transporter 1 (CTR1) expression by mouse testicular germ cells, but not Sertoli cells, is essential for functional spermatogenesis.
    Ghaffari R; Di Bona KR; Riley CL; Richburg JH
    PLoS One; 2019; 14(4):e0215522. PubMed ID: 31002737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of orally administered triethylenetetramine dihydrochloride: a therapeutic drug for Wilson's disease.
    Kodama H; Meguro Y; Tsunakawa A; Nakazato Y; Abe T; Murakita H
    Tohoku J Exp Med; 1993 Jan; 169(1):59-66. PubMed ID: 8211970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical PET imaging study of lung cancer with
    Wang Q; Song D; Ma X; Wu X; Jiang L
    Ann Nucl Med; 2020 Sep; 34(9):653-662. PubMed ID: 32567008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes-induced alterations in tissue collagen and carboxymethyllysine in rat kidneys: Association with increased collagen-degrading proteinases and amelioration by Cu(II)-selective chelation.
    Brings S; Zhang S; Choong YS; Hogl S; Middleditch M; Kamalov M; Brimble MA; Gong D; Cooper GJ
    Biochim Biophys Acta; 2015 Aug; 1852(8):1610-8. PubMed ID: 25900786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats.
    Gong D; Lu J; Chen X; Choong SY; Zhang S; Chan YK; Glyn-Jones S; Gamble GD; Phillips AR; Cooper GJ
    Mol Pharmacol; 2006 Dec; 70(6):2045-51. PubMed ID: 16973718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.
    Hyvönen MT; Ucal S; Pasanen M; Peräniemi S; Weisell J; Khomutov M; Khomutov AR; Vepsäläinen J; Alhonen L; Keinänen TA
    Biochem J; 2016 May; 473(10):1433-41. PubMed ID: 27001865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor recovers suppressed cytochrome c oxidase activity by restoring copper availability in hypertrophic cardiomyocytes.
    Sun M; Zuo X; Li R; Wang T; Kang YJ
    Exp Biol Med (Maywood); 2014 Dec; 239(12):1671-7. PubMed ID: 25107896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How trimerization of CTR1 N-terminal model peptides tunes Cu-binding and redox-chemistry.
    Galler T; Lebrun V; Raibaut L; Faller P; Wezynfeld NE
    Chem Commun (Camb); 2020 Oct; 56(81):12194-12197. PubMed ID: 32914794
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Parmar A; Pascali G; Voli F; Lerra L; Yee E; Ahmed-Cox A; Kimpton K; Cirillo G; Arthur A; Zahra D; Rahardjo G; Liu GJ; Lengkeek N; Saletta F; Charil A; Kavallaris M; Vittorio O
    Theranostics; 2018; 8(20):5645-5659. PubMed ID: 30555570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
    Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR
    J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cu(II) affinity of the N-terminus of human copper transporter CTR1: Comparison of human and mouse sequences.
    Bossak K; Drew SC; Stefaniak E; Płonka D; Bonna A; Bal W
    J Inorg Biochem; 2018 May; 182():230-237. PubMed ID: 29402466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.